Circulating amyloid-β peptide crosses the blood–brain barrier in aged monkeys and contributes to Alzheimer's disease lesions
- 30 June 2002
- journal article
- research article
- Published by Elsevier BV in Vascular Pharmacology
- Vol. 38 (6), 303-313
- https://doi.org/10.1016/s1537-1891(02)00198-2
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid AngiopathyJournal of Drug Targeting, 2002
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2001
- Metabolic Regulation of Brain Aβ by NeprilysinScience, 2001
- Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease PedigreesScience, 2000
- Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'Nature Medicine, 2000
- Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tauNature Neuroscience, 1998
- Intra-arterial infusion of [125l]Aβ 1–40 labels amyloid deposits in the aged primate brain in vivoNeuroReport, 1996
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsOnline Journal of Public Health Informatics, 1996
- β-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathyNeurobiology of Aging, 1995